STOCK TITAN

Amrize Ltd SEC Filings

AMRZ NYSE

Amrize Ltd filings document a Swiss-incorporated North American building-solutions company with ordinary shares listed on the New York Stock Exchange and SIX Swiss Exchange. The company’s SEC reports include Form 8-K disclosures for quarterly and annual financial results, Regulation FD investor materials, dividend-related events, auditor changes, and board or executive appointments.

Proxy and annual meeting filings cover shareholder voting, board elections, compensation matters, distributions from legal reserves from capital contributions, and governance procedures under the company’s Swiss corporate structure. The filing record also documents Amrize’s completed spin-off from Holcim and related public-company reporting matters.

Rhea-AI Summary

Amrize Ltd Chairman & CEO Jenisch Jan Philipp reported open-market purchases of 28,417 Ordinary Shares on May 15, 2026. The transactions included 7,000 shares bought indirectly through his spouse and two direct purchases of 8,000 and 13,417 shares at prices around $49 per share.

After these trades, the filing shows direct ownership totals of 1,724,999 and 1,716,999 Ordinary Shares reported following the respective purchases, and 512,000 shares held indirectly. A footnote notes one purchase was executed at CHF 39.05 per share and converted into U.S. dollars using the transaction-date exchange rate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amrize Ltd Chief People Officer buys shares on the open market. On this Form 4, Stephen S. Clark reported an open-market purchase of 2.152 Ordinary Shares at $52.75 per share. After the transaction, he directly holds 5,260 Ordinary Shares, including 258 shares acquired under the Amrize Ltd 2025 Employee Stock Purchase Plan on December 31, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amrize Ltd reported first-quarter 2026 revenue of $2,178 million, up from $2,081 million a year earlier, but results weakened as costs rose. Net loss increased to $118 million, or $0.21 per share, versus a $87 million loss, while Adjusted EBITDA declined to $192 million from $214 million.

Operating cash flow was negative $896 million, reflecting seasonal working capital and higher investment. Amrize closed the $425 million PB Materials acquisition to expand its Building Materials footprint, approved $1.0 billion of share repurchases, and authorized special and ordinary dividends of up to $0.88 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

Amrize Ltd reported first-quarter 2026 revenues of $2.178 billion, up 4.7% from 2025, driven by strong Building Materials demand. Net loss widened to $118 million and Adjusted EBITDA fell 10.3% to $192 million, reflecting weaker roofing volumes and pricing in Building Envelope.

Building Materials revenues rose to $1.5 billion with Segment Adjusted EBITDA up 41.7% to $170 million, supported by double-digit growth in cement and aggregates and the PB Materials acquisition. Building Envelope revenues declined to $678 million and Segment Adjusted EBITDA dropped to $78 million.

The Board declared a first quarterly dividend of $0.11 per share payable May 20, 2026, as the first installment of an annual dividend of up to $0.44 per share, and approved a $1.0 billion share repurchase program with a 12‑month expiration. Amrize reaffirmed full‑year 2026 guidance for revenues of $12.29–$12.52 billion and Adjusted EBITDA of $3.25–$3.34 billion, implying 4–6% revenue growth and 8–11% Adjusted EBITDA growth. Net Debt was $4.947 billion with a Net Leverage Ratio of 1.7x as of March 31, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.27%
Tags
current report
-
Rhea-AI Summary

Amrize Ltd: Vanguard Capital Management reports beneficial ownership of 30,177,619 shares of Common Stock, representing 5.32% of the class as of 03/31/2026. The filing states Vanguard has sole voting power for 9,549,189 shares and sole dispositive power for 30,177,619 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Amrize Ltd director Nicholas C. Gangestad reported routine equity compensation activity. He received a grant of 2,976 Ordinary Shares as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the company’s next regular annual shareholder meeting.

On the same date, 740 Ordinary Shares were disposed of as a tax-withholding transaction at a reference price of $57.12 per share, covering tax obligations tied to the vesting. Following these transactions, Gangestad directly owns 4,218 Ordinary Shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amrize Ltd director Gibson Dwight Audley Konrad reported routine equity compensation activity. He acquired 2,976 Ordinary Shares at no cost as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan.

In connection with the vesting, 740 shares were disposed of to cover tax obligations at a price of $57.12 per share, a tax-withholding mechanism rather than an open-market sale. Following these transactions, he holds 2,218 Ordinary Shares directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amrize Ltd director Wilbur Maria Cristina Alapag received a share-based compensation award. On April 21, 2026, Alapag acquired 2,976 Ordinary Shares at $0.00 per share as part of a restricted stock unit (RSU) award under the Amrize Ltd 2025 Omnibus Incentive Plan.

The filing also reports a related tax-withholding disposition of 190 Ordinary Shares at $57.12 per share, used to cover tax obligations on the vesting. Following these transactions, Alapag directly holds 2,958 Ordinary Shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amrize Ltd director Sanche Jacques Wolf received an equity award of 2,976 Ordinary Shares as a restricted stock unit grant. The award was made at a price of $0.0000 per share under the Amrize Ltd 2025 Omnibus Incentive Plan and is described as a grant, award, or other acquisition.

The restricted stock units vest on the earlier of the one-year anniversary of the grant date and the date of Amrize Ltd's next regular annual meeting of shareholders. Following this grant, Wolf holds 5,616 Ordinary Shares directly and an additional 40 Ordinary Shares indirectly through a child.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amrize Ltd director Robert S. Rivkin reported a share-based compensation event involving company ordinary shares. He received a grant of 2,976 shares at no cash cost as part of a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan.

In connection with the vesting of these restricted stock units, 740 shares were disposed of at a price of $57.12 per share to cover tax obligations, based on the closing price on the trading date of vesting. Following these transactions, his directly held ordinary shares were reported at 2,218.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Amrize (AMRZ) SEC filings are available on StockTitan?

StockTitan tracks 85 SEC filings for Amrize (AMRZ), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Amrize (AMRZ)?

The most recent SEC filing for Amrize (AMRZ) was filed on May 18, 2026.